According to Mesoblast
's latest financial reports the company has $0.50 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-06-30 | $0.50 B | 0.96% |
2022-06-30 | $0.49 B | -14.51% |
2021-06-30 | $0.58 B | 5.84% |
2020-06-30 | $0.54 B | 14.19% |
2019-06-30 | $0.48 B | -11.9% |
2018-06-30 | $0.54 B | 5.66% |
2017-06-30 | $0.51 B | -2.16% |
2016-06-30 | $0.52 B | 12.86% |
2015-06-30 | $0.46 B | -18.14% |
2014-06-30 | $0.57 B | -9.29% |
2013-06-30 | $0.63 B | 31.62% |
2012-06-30 | $0.47 B | -7.17% |
2011-06-30 | $0.51 B | 1260.38% |
2010-06-30 | $37.91 M | 47.03% |
2009-06-30 | $25.78 M | -1.63% |
2008-06-30 | $26.21 M | 27.64% |
2007-06-30 | $20.53 M | 71.66% |
2006-06-30 | $11.96 M | -37.89% |
2005-06-30 | $19.26 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.88 M | -100.57% | Bahamas |
NRC Health
NRC | $48.95 M | -90.24% | ๐บ๐ธ USA |